To include your compound in the COVID-19 Resource Center, submit it here.
INDICATION: Breast cancer; ovarian cancer; prostate cancer
Cell culture and mouse studies suggest combining PARP and BET bromodomain proteins inhibitors could help treat homologous recombination
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury